An observational study in Spinal Cord Injuries, Autonomic Dysreflexia and UDS Filling Speed, sponsored by Pusan National University Yangsan Hospital. Recruiting at 1 site in South Korea. Per ClinicalTrials.gov, last updated 2026-01-14.
Sponsored by Pusan National University Yangsan Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
In patients with spinal cord injury, the investigators want to understand and understand the differences in AD prevalence and characteristics according to bladder injection rate, and to determine which factors have a greater influence between bladder expansion or injection rate.
It has been reported that there is a difference in the degree of AD between the bladder and urinary tract motility tests, suggesting a potential difference according to the injection rate. According to Liu et al., the authors noted that stimulation of the urethra, prostate, and internal sphincter appears to induce AD more strongly than the injection rate. In addition, the two main factors contributing to AD among urinary kinetics tests are the patient's age and bladder maximum urination pressure. Considering these factors is important in preventing AD during urinary kinetics tests. Despite these previous studies, the prevalence and severity of AD according to the injection rate of urinary kinetics tests in SCI have not been quantitatively evaluated.
30 studies on the registry are indexed under Autonomic Dysreflexia; 10 are open to participants now.
Browse Autonomic Dysreflexia studies →Pusan National University Yangsan Hospital is the lead sponsor of 108 studies on the registry; 27 are open to participants now.
Compared within Autonomic Dysreflexia, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Spinal Cord Injuries. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Chronic spinal cord injuries
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Urodynamic testing is performed using saline solution at the same temperature as body temperature (37 degrees) at two injection speeds of 10 mL/min and 100 mL/min, respectively.
Bladder volume (ml)
(1) at first AD at an infusion rate of 10 mL/min (2) at first AD at an infusion rate of 100 mL/min
Time frame: Immediately after the test
Bladder compliance (mL/cmH2O)
Bladder compliance
Time frame: Immediately after the test
Symptoms (Y/N)
Symptoms
Time frame: Immediately after the test
Blood pressure (mmHg)
Blood pressure
Time frame: Immediately after the test
Heart rate (bpm)
Heart rate
Time frame: Immediately after the test
Plan to share: No
No publications or documents are linked to this record.
Started Jan 2025 (actual). Primary completion is estimated for Aug 2026, 19 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Pusan National University Yangsan Hospital →